Jazz Venture Partners
Venture Capital
Active
San Francisco, United States
81
28M
47
9.00
15
0.42
5
- Areas of investment
Summary
Jazz Venture Partners appeared to be the VC, which was created in 2015. The venture was found in North America in United States. The main department of described VC is located in the San Francisco.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Pear Therapeutics, Akili Interactive Labs, Augment CXM. Among the most successful fund investment fields, there are Consumer Electronics, Artificial Intelligence. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.
The current fund was established by Adam Gazzaley, Andrew Firlik, John Harris, John Spinale, Zack Lynch. We also calculated 10 valuable employees in our database.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Jazz Venture Partners, startups are often financed by Intel Capital, Randstad Innovation Fund, Lux Capital. The meaningful sponsors for the fund in investment in the same round are Intel Capital, Arboretum Ventures, Temasek Holdings. In the next rounds fund is usually obtained by Temasek Holdings, Novartis, M Ventures.
The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2016. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The average startup value when the investment from Jazz Venture Partners is 100-500 millions dollars. The fund is constantly included in 2-6 deals per year. This Jazz Venture Partners works on 24 percentage points less the average amount of lead investments comparing to the other organizations.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 278000000
- Fund raised date
- 2019-06-05
Analytics
- Total investments
- 81
- Lead investments
- 15
- Exits
- 5
- Rounds per year
- 9.00
- Follow on index
- 0.42
- Investments by industry
- Health Care (27)
- Therapeutics (20)
- Software (19)
- Biotechnology (16)
- Medical (13) Show 72 more
- Investments by region
-
- United States (73)
- Germany (4)
- Finland (1)
- Israel (1)
- Canada (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 53M
- Group Appearance index
- 0.91
- Avg. company exit year
- 6
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Enveda Biosciences | 14 Jun 2024 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 55M | United States, California, San Francisco |
| NextStep | 09 Apr 2020 | Human Resources, Training, Education, Staffing Agency | Seed | 3M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.